Securing commitment and control for the supply of plasma derivatives for public health systems. II: A survey of national pathways

Documents similaires

• Securing commitment and control for the supply of plasma derivatives for public health systems. I: A short review of the global landscape
  par: Leni von Bonsdorff, et autres
  Publié: (2024)
• Generating pathways to domestically sourced plasma‐derived medicinal products: Report from a workshop by the International Plasma and Fractionation Association and the Working Party on Global Blood Safety of the International Society of Blood Transfusion
  par: Albert Farrugia, et autres
  Publié: (2024)
• Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection
  par: Jean‐Baptiste Thibert, et autres
  Publié: (2026)
• Immunoglobulin solutions for patients with primary immunodeficiency. Comments on Burnouf et al.'s ‘Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low‐ and middle‐income countries’
  par: Martine Pergent, et autres
  Publié: (2024)
• Organizational monitoring of patient blood management implementation: Results of an Italian national survey
  par: Vanessa Agostini, et autres
  Publié: (2026)